Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research
Tóm tắt
ONJ has been increasingly suspected to be a potential complication of bisphosphonate therapy in recent years. Thus, the ASBMR leadership appointed a multidisciplinary task force to address key questions related to case definition, epidemiology, risk factors, diagnostic imaging, clinical management, and future areas for research related to the disorder. This report summarizes the findings and recommendations of the task force.
Introduction: The increasing recognition that use of bisphosphonates may be associated with osteonecrosis of the jaw (ONJ) led the leadership of the American Society for Bone and Mineral Research (ASBMR) to appoint a task force to address a number of key questions related to this disorder.
Materials and Methods: A multidisciplinary expert group reviewed all pertinent published data on bisphosphonate-associated ONJ. Food and Drug Administration drug adverse event reports were also reviewed.
Results and Conclusions: A case definition was developed so that subsequent studies could report on the same condition. The task force defined ONJ as the presence of exposed bone in the maxillofacial region that did not heal within 8 wk after identification by a health care provider. Based on review of both published and unpublished data, the risk of ONJ associated with oral bisphosphonate therapy for osteoporosis seems to be low, estimated between 1 in 10,000 and <1 in 100,000 patient-treatment years. However, the task force recognized that information on incidence of ONJ is rapidly evolving and that the true incidence may be higher. The risk of ONJ in patients with cancer treated with high doses of intravenous bisphosphonates is clearly higher, in the range of 1–10 per 100 patients (depending on duration of therapy). In the future, improved diagnostic imaging modalities, such as optical coherence tomography or MRI combined with contrast agents and the manipulation of image planes, may identify patients at preclinical or early stages of the disease. Management is largely supportive. A research agenda aimed at filling the considerable gaps in knowledge regarding this disorder was also outlined.
Từ khóa
Tài liệu tham khảo
Shane, 2006, Osteonecrosis of the jaw: More research needed, J Bone Miner Res, 10, 1503, 10.1359/jbmr.060712
Sambrook, 2006, Bisphosphonates and osteonecrosis of the jaw, Aust Family Phys, 35, 801
Felsenberg, 2006, Bisphosphonattherapie assoziierte, Kiefernekrosen Deutsches Arzteblatt, 46, A3078
Mavrokokki, 2007, Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia, J Oral Maxillofac Surg, 65, 415, 10.1016/j.joms.2006.10.061
Body, 2003, Effectiveness and cost of bisphosphonate therapy in tumor bone disease, Cancer, 97, 859, 10.1002/cncr.11139
Ramaswamy, 2003, Bisphosphonates in the prevention and treatment of bone metastases, Oncology (Williston Park), 17, 1261
Hillner, 2003, American Society of Clinical Oncology update on the role of bisphosphonates and bone health issues in women with breast cancer, J Clin Oncol, 21, 4042, 10.1200/JCO.2003.08.017
Berenson, 2002, American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma, J Clin Oncol, 20, 3719, 10.1200/JCO.2002.06.037
Coleman, 2004, Bisphosphonates: Clinical experience, The Oncologist, 9, 14, 10.1634/theoncologist.9-90004-14
Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004
Woo, 2006, Systematic review: Bisphosphonates and osteonecrosis of the jaws, Ann Intern Med, 144, 753, 10.7326/0003-4819-144-10-200605160-00009
Durie, 2005, Osteonecrosis of the jaw and bisphosphonates, N Engl J Med, 353, 99, 10.1056/NEJM200507073530120
Hoff, 2006, Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy, Clin Oncol, 24, 8528
Van Poznak, 2004, Osteonecrosis of the maxilla and mandible in patients with metastatic breast cancer, J Bone Miner Res, 19, S227
Maerevoet, 2005, Osteonecrosis of the jaw and bisphosphonates, N Engl J Med, 353, 99, 10.1056/NEJM200507073530120
Zavras, 2006, Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: Is it osteonecrosis?, J Oral Maxillorfac Surg, 64, 917, 10.1016/j.joms.2006.02.011
Bamias, 2005, Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors, J Clin Oncol, 23, 8580, 10.1200/JCO.2005.02.8670
American Dental Association Division of Communications, 2002, For the patient: Oral care for cancer patients, J Am Dent Assoc, 133, 1014, 10.14219/jada.archive.2002.0308
Migliorati, 2005, Managing the care of patients with bisphosphonate-associated osteonecrosis. An American Academy of Oral Medicine position paper, J Am Dent Assoc, 136, 1658, 10.14219/jada.archive.2005.0108
Ruggiero, 2006, Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer, J Oncol Pract, 2, 7, 10.1200/jop.2006.2.1.7
Marx, 2005, Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment, J Oral Maxillofac Surg, 63, 1567, 10.1016/j.joms.2005.07.010
Estilo, 2004
Chiandussi, 2006, Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws, Dentomaxillofac Radiol, 35, 236, 10.1259/dmfr/27458726
Store, 2000, Mandibular osteoradionecrosis: Clincal behavious and diagnostic aspects, Clin Otolaryngol, 25, 378, 10.1046/j.1365-2273.2000.00367.x
Store, 1999, Mandibular osteoradionecrosis: A comparison of computed tomography with panoramic radiography, Dentomaxillofac Radiol, 28, 295, 10.1038/sj.dmfr.4600461
Schulze, 2006, Diagnostic criteria for the detection of mandibular osteomyelitis using cone-beam computed tomography, Dentomaxillofac Radiol, 35, 232, 10.1259/dmfr/71331738
Guerrero, 2006, State-of-the-art on cone beam CT imaging for preoperative planning of implant placement, Clin Oral Investig, 10, 1, 10.1007/s00784-005-0031-2
Gabriel, 1994, MR imaging of hip disorders, Radiographics, 14, 763, 10.1148/radiographics.14.4.7938767
Larheim, 1999, Osteonecrosis of the temporomandibular joint: Correlation of magnetic resonance imaging and histology, J Oral Maxillofac Surg, 57, 888, 10.1016/S0278-2391(99)90001-0
Colston, 2000, Imaging of the oral cavity using optical coherence tomography, Monogr Oral Sci, 17, 32, 10.1159/000061643
Hall, 2004, A review of potential new diagnostic modalities for caries lesions, J Dent Res, 83, C89, 10.1177/154405910408301s18
Baumgartner, 2000, Polarization-sensitive optical coherence tomography of dental structures, Caries Res, 34, 59, 10.1159/000016571
American Dental Association, 2006, Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations, J Am Dent Assoc., 137, 1144, 10.14219/jada.archive.2006.0355
American Association of Endodontists (AAE) Special Committee on Bisphosphonates, 2006
Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004
Ruggiero, 2006, Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management, Oral Surg Oral Med Oral Path Oral Radiol Endod, 102, 433, 10.1016/j.tripleo.2006.06.004
Melo, 2006, Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: Strategies for prevention and early recognition, J Am Dent Assoc, 136, 1675, 10.14219/jada.archive.2005.0110
Cheng, 2005, The dental implications of bisphosphonates and bone disease, Aust Dent J, 50, S4, 10.1111/j.1834-7819.2005.tb00384.x
Marunick, 2005, Adverse oral sequelae to bisphosphonate administration, J Mich Dent Assoc, 87, 44
Purcell, 2005, Bisphosphonates and osteonecrosis of the jaw, Med J Aust, 182, 417, 10.5694/j.1326-5377.2005.tb06762.x
Farrugia, 2006, Osteonecrosis of the Mandible or Maxilla Associated with the use of New Generation Bisphosphonates, Laryngoscope, 116, 115, 10.1097/01.mlg.0000187398.51857.3c
Chang, 2004
Starck, 1995, Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report, Int J Oral Maxillofac Implants, 10, 74
Hoefert, 2005, Necrosis of the jaws under bisphosphonate therapy, Orthopade, 35, 204, 10.1007/s00132-005-0901-y
Najm, 2005, Osteonecrose des maxillaries chez des patients traits par bisphosphonates, J Presse Med, 34, 1073, 10.1016/S0755-4982(05)84119-3
Carter, 2005, Bisphosphonates and avascular necrosis of the jaw: A possible association, Med J Aust, 182, 413, 10.5694/j.1326-5377.2005.tb06761.x